When the hospital germ Pseudomonas aeruginosa infects the body, it uses the sugar-binding protein LecA to attach itself to human cells, invade them, and form so-called biofilms. LecA thus plays a central role in the...
Liver transplants often save the lives of seriously ill patients. However, there remains a risk that the body will reject the new organ. Doctors distinguish between acute and chronic rejection. While acute rejection is...
To mark its 60th anniversary, the Helmholtz Centre for Infection Research (HZI) is bringing its research to the heart of Braunschweig's city center from 3 to 17 December 2025. Under the motto “Bringing science to life...
A novel oral immunotherapy for cancer and a drug for treating chronic liver fibrosis: What many patients are hoping for is already a part of cutting-edge research in Lower Saxony. To ensure that such innovative ideas...
In Germany, around 10,000 people die every year from antibiotic-resistant pathogens. At the Helmholtz Centre for Infection Research (HZI) and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS),...
PhD students play a crucial role in the advancement of knowledge and technologies that shape our world. At the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its locations, more than 300 doctoral...
Since the middle of the 20th century, antibiotics have been among the greatest successes in medicine. They save millions of lives every year, prevent complications during operations and make many therapies possible in...
The company Clarivate Analytics publishes an annual list of “Highly-cited Researchers” to recognize scientists whose publications have had a particularly large impact on their field. In 2025, three researchers from the...
During the 20th anniversary celebrations of the Academy of Sciences in Hamburg , Fabian Leendertz, founding director of the Helmholtz Institute for One Health (HIOH), was inducted as a full member. The ceremony took...